Cargando…

All in the family: back-to-back kinase inhibitors for the treatment of chronic lymphocytic leukemia

Detalles Bibliográficos
Autores principales: Thompson, Meghan C., Roeker, Lindsey E., Mato, Anthony R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409031/
https://www.ncbi.nlm.nih.gov/pubmed/33730846
http://dx.doi.org/10.3324/haematol.2021.278535
_version_ 1783746912556417024
author Thompson, Meghan C.
Roeker, Lindsey E.
Mato, Anthony R.
author_facet Thompson, Meghan C.
Roeker, Lindsey E.
Mato, Anthony R.
author_sort Thompson, Meghan C.
collection PubMed
description
format Online
Article
Text
id pubmed-8409031
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-84090312021-09-08 All in the family: back-to-back kinase inhibitors for the treatment of chronic lymphocytic leukemia Thompson, Meghan C. Roeker, Lindsey E. Mato, Anthony R. Haematologica Editorials Fondazione Ferrata Storti 2021-09-01 /pmc/articles/PMC8409031/ /pubmed/33730846 http://dx.doi.org/10.3324/haematol.2021.278535 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Editorials
Thompson, Meghan C.
Roeker, Lindsey E.
Mato, Anthony R.
All in the family: back-to-back kinase inhibitors for the treatment of chronic lymphocytic leukemia
title All in the family: back-to-back kinase inhibitors for the treatment of chronic lymphocytic leukemia
title_full All in the family: back-to-back kinase inhibitors for the treatment of chronic lymphocytic leukemia
title_fullStr All in the family: back-to-back kinase inhibitors for the treatment of chronic lymphocytic leukemia
title_full_unstemmed All in the family: back-to-back kinase inhibitors for the treatment of chronic lymphocytic leukemia
title_short All in the family: back-to-back kinase inhibitors for the treatment of chronic lymphocytic leukemia
title_sort all in the family: back-to-back kinase inhibitors for the treatment of chronic lymphocytic leukemia
topic Editorials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409031/
https://www.ncbi.nlm.nih.gov/pubmed/33730846
http://dx.doi.org/10.3324/haematol.2021.278535
work_keys_str_mv AT thompsonmeghanc allinthefamilybacktobackkinaseinhibitorsforthetreatmentofchroniclymphocyticleukemia
AT roekerlindseye allinthefamilybacktobackkinaseinhibitorsforthetreatmentofchroniclymphocyticleukemia
AT matoanthonyr allinthefamilybacktobackkinaseinhibitorsforthetreatmentofchroniclymphocyticleukemia